Falcon تطلق برامج للدراسات العليا بالتعاون مع Fujairah Aviation Academy

دبي، الإمارات العربية المتحدة،, March 13, 2025 (GLOBE NEWSWIRE) — في خطوة تهدف إلى إعداد الجيل المقبل من القادة وتطوير مهاراتهم، وقّعت شركة Falcon مذكرة تفاهم مع أكاديمية الفجيرة للطيران Fujairah Aviation Academy لإطلاق برامج للدراسات العليا مصمّمة خصيصاً لتكون بمثابة منصة إطلاق للخريجين الجدد والمهنيين في المراحل المبكرة من مسيرتهم المهنية، تشمل ما يلي:

التطوير الوظيفي للمختصّين في مجال الطيران، بما في ذلك المهندسين والطيارين*

التوظيف وفرص التدريب للطلاب والخرّيجين الجدد*

خدمات التدريب والترخيص*

تأسست أكاديمية الفجيرة للطيران Fujairah Aviation Academy في عام 1986 تحت رعاية صاحب السمو الشيخ صالح بن محمد بن حمد الشرقي، وهي أكاديمية الطيران الأولى في منطقة مجلس التعاون الخليجي. تقدم الأكاديمية مجموعة من الدورات التدريبية المتميزة في مجال تدريب الطيارين ودورات هندسة صيانة الطائرات، مدعومة بأسطول متقدم من الطائرات والمرافق، ما ساهم في تعزيز مكانتها كأكبر أكاديمية للتدريب على الطيران في منطقة الشرق الأوسط.

منذ تأسيسها، ساهمت أكاديمية الفجيرة للطيران Fujairah Aviation Academy في تخريج نخبة من الطيارين والفنيين ذوي الكفاءات العالية سمحت لهم بالانضمام إلى كبرى شركات الطيران المحلية والدولية، وهذا يجعل منها الخيار المفضل لعشاق الطيران. وبفضل التزامها الراسخ بالتميز، تواصل الأكاديمية رسم معالم مستقبل الطيران من خلال خدمات التعليم والتدريب عالية الجودة.

في هذا السياق، قال السيد Sultan Rashit Abdulla Rashit Al Shene، مؤسس ورئيس مجلس إدارة Alex Group Investments، الشركة الأم لشركة Falcon: “يتمثّل هدفنا من إطلاق برامج الدراسات العليا في تمكين الجيل المقبل من المتخصصين في مجال الطيران من خلال منهج تطوير استراتيجي ومصمم خصيصاً ليتيح لهم مباشرة مسيرتهم المهنية.”

في إطار هذه البرامج، سيحظى المتدربون والخريجون بفرصة لاستكشاف الأنشطة الغنية والمتنوعة في قطاع الطيران من خلال التناوب على العمل في عدد من المناصب المختلفة، عبر وحدات وأقسام شركة Falcon، وعلى مستوى المجموعة. من شأن هذه الطريقة أن تتيح للمتدربين والخرّيجين الاستفادة من إرشادات وتوجيهات كبار القادة ومن الفرص اللامتناهية لتوسيع شبكتهم المهنية وإطلاق العنان لإمكاناتهم الكاملة.

من جانبه، أكد Captain Yahya Mohammed Saleh Al Boloushi، مدير عام أكاديمية الفجيرة للطيران Fujairah Aviation Academy، حرص الأكاديمية المستمر على تطوير قطاع الطيران، تماشياً مع التزام دولة الإمارات القوي بتمكين الموارد البشرية. كما سلّط الضوء على أهمية استقطاب المواهب الجديدة وتأهيلها، باعتبارها ركيزة أساسية في تلبية متطلبات السوق وضمان الازدهار وتعزيز التنمية المستدامة في البلاد.

وفي إطار هذا الالتزام، شدّد Captain Al Boloushi على الدور الحيوي الذي تضطلع به مثل هذه الشراكات في إرساء أساس متين لعلاقات مثمررة وطويلة الأمد بين مختلف الشركاء. وتهدف هذه المبادرة إلى تحقيق أقصى قدر من الفوائد عبر توفير البرامج التدريبية الاحترافية المصمّمة خصيصاً لموظفي Falcon. تشمل هذه البرامج الامتحانات المتعلقة بالطيران، ودورات في أساسيات تشريعات الطيران، وبرامج التدريب المتخصصة لمهندسي صيانة الطائرات. وتهدف أكاديمية الفجيرة للطيران Fujairah Aviation Academy من خلال هذا التعاون إلى التأكيد على التزامها الراسخ بالتميز في مجال تعليم وتدريب الطيران، بما يضمن محافظة دولة الإمارات العربية المتحدة على مكانتها كرائدة عالمياً في قطاع الطيران.

وقد أظهرت نتائج دراسة أجرتها شركة البحوث العالمية الرائدة Oxford Economics، أنه من المتوقع أن يُساهم قطاع الطيران بما قيمته 32 في المائة من الناتج المحلي الإجمالي لدبي، وفي توفير ما يُعادل وظيفة واحدة من كل أربع وظائف في الإمارة بحلول عام 2030. كذلك، سيُساهم قطاع الطيران بمبلغ 53.36 مليار دولار أمريكي إلى الناتج المحلي الإجمالي لدبي، ويدعم 816 ألف وظيفة بحلول عام 2030.

لمحة عن شركة Falcon

تُعد Falcon شركة رائدة في مجال توفير خدمات الطيران، وهي ملتزمة بتقديم مستويات استثنائية من الرفاهية والسلامة والراحة في مختلف جوانب الطيران الخاص. وتضم الشركة أربع علامات تجارية وهي: Falcon Luxe، وهو أسطول من الطائرات الخاصة الحديثة المتاحة للاستئجار العالمي؛ و Falcon Elite، وهي شبكة دولية من المحطات الخاصة الفاخرة (FBOs)؛ و Falcon Technic، وهي شركة تقدم مجموعة كاملة من خدمات الصيانة والإصلاح والفحص؛ و Falcon Flight Support، التي تضمن أن تجري كل الرحلات بسلاسة. انطلاقاً من التكنولوجيا البديهية وصولاً إلى الخدمات الاستباقية والتي تتسم باحترام الخصوصية، تهتم الشركة بأدق التفاصيل؛ لكي لا تشغلوا أنفسكم بها. للمزيد من المعلومات، يُرجى زيارة الموقع الإلكتروني للشركة: flyfalcon.com أو زيارة صفحاتها على “إنستغرام” و“لينكد إن”.

يمكنكم الإطلاع على الصورة المرفقة بهذا البيان الصحفي عبر الرابط الإلكتروني التالي: 

https://www.globenewswire.com/NewsRoom/AttachmentNg/2582e168–fd8e–4d9b–8408–2d12d2e34f9c


GLOBENEWSWIRE (Distribution ID 1001053664)

AgDevCo Successfully Exits Saise Farming Enterprises, Strengthening Zambia’s Potato Industry

LUSAKA, Zambia, March 13, 2025 (GLOBE NEWSWIRE) — AgDevCo is pleased to announce its successful exit from Saise Farming Enterprises Limited, through an equity sale to Buya Bamba Limited, a leading Zambian potato company.

Saise was established in 2016 as a specialised potato seed farm between AgDevCo, Buya Bamba and its managing partners. Saise has played a crucial role in developing Zambia’s potato sector by producing high– quality, early–generation seed potatoes which are carefully chosen for Zambia’s climate and grown under licence from Buya Bamba.

With 285 hectares under irrigation in Mbala, Northern Zambia, Saise's seed potatoes are multiplied by a
network of growers, reaching a large portion of the country’s potato farmers. The farm has been instrumental in improving seed availability, enhancing yields, and enabling a reliable local source of excellent quality potato seed for Zambia. Additionally, Saise has created much–needed formal employment in Northern Zambia.

“Saise is in excellent hands with Buya Bamba, our partner in the venture from the start and are grateful for the commitment from our managing partners to build Saise into what it is today. As a proudly Zambian company, Buya Bamba is well–positioned to continue growing Zambia’s potato industry,” said Sean Carey, South Region Managing Director at AgDevCo.

Anthony Barker, Managing Director of Buya Bamba, added, “The future of Zambia’s potato industry is bright and this acquisition further strengthens the Zambian potato value chain. Buya Bamba appreciates the effort from AgDevCo to jointly lead the development of Saise, and take the early stage investment risk of this successful greenfield project.”

After successfully closing its latest US$85 million fund raise in 2024, AgDevCo remains committed to supporting pioneering agribusinesses across Zambia and Sub–Saharan Africa and is actively seeking opportunities to invest in sustainable farming and agri–processing ventures in Zambia and across the region.

About AgDevCo:

AgDevCo is a specialist impact investor operating exclusively in the agriculture sector in Africa. Our mission is to build successful African agribusinesses through long–term investment and support to deliver positive impact at scale. We invest debt and equity in African agribusinesses to create jobs, improve food security, and boost prosperity. With $340 million assets under management, we have made over 88 investments to date. Our investments leverage private capital into socially–responsible farming and agri–processing businesses in Africa, with major benefits for smallholder farmers and local communities.

Contact for media enquiries: Sean Carey, Managing Director South Region; Tel: +44 (0) 20 7539 2650; email [email protected] or [email protected]

About Buya Bamba:

Buya Bamba is a Zambian agribusiness company specializing in the production, marketing, storage, and distribution of high–quality potatoes. The company plays a key role in strengthening Zambia’s agricultural value chain by supplying locally grown potatoes to agro–processing industries, supermarkets, restaurants, and commercial buyers. Buya Bamba strongly supports the informal sector through its sales depots which create income generating opportunities downstream.

Contact for media enquiries: Anthony Barker, Managing Director; Tel: +260 966 861 140; email [email protected]

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/52b0d869–9304–42ab–8487–898b578d8c7f

https://www.globenewswire.com/NewsRoom/AttachmentNg/78206b1c–0ee8–4b6a–b1e7–8e6738dad3ee


GLOBENEWSWIRE (Distribution ID 1001053468)

Our Investment in School Meals is Our Investment in Education

By Yasmine Sherif
NEW YORK, Mar 13 2025 (IPS-Partners)

Millions of children worldwide are going hungry, and we all know that hungry children cannot learn. On International School Meals Day, we are calling on donors to significantly scale-up funding for school feeding to ensure every child can go to school, every child can access at least one nutritious meal a day, and every child can concentrate, develop and achieve.

Our investment in school meals saves lives through education in emergencies. It also offers significant economic returns that pave the way for strong economies and increased global security. In fact, according to the World Food Programme (WFP) State of School Feeding Worldwide Report, every dollar invested in school meals has a $9 return. These returns cut across numerous sectors, including agriculture, education, health and nutrition, and social protection.

The benefits for learners are significant. According to WFP: “Every day, over 100 million children in low- and lower-middle-income countries are going hungry. Millions go to school on an empty stomach – hunger affects their concentration and ability to learn. There are also millions – particularly girls – who simply do not go to school because their families need them to help in the fields or perform domestic duties. In conflict-affected countries, children are twice as likely to be out of school than their peers in stable countries – 2.5 times more likely, in the case of girls.”

Investing in healthy school meals – especially in crisis contexts – is an investment in local economies and an investment in local human capital. It’s an investment in the future engineers, teachers and technicians that will drive positive change to end repeated cycles of hunger, displacement and poverty.

Working together with partners, ECW provides significant investments each year in school feeding. The most recent analysis indicates that ECW investments for quality school feeding interventions active in 2023 reached over 300,000 children across nine countries.

In Ethiopia, ECW investments reached around 100,000 children through school feeding programmes. Recognizing that poverty was a crucial factor keeping children out of school, the programme involved families and community members to manage the programme and provide in-kind contributions like building kitchen houses or providing firewood to cook the hot meals.

In Cameroon and Haiti, ECW funding delivered by WFP is focused on local procurement from smallholder farmers. This not only ensures nutritious meals for young learners, but also strengthens the local food system and local economy.

In the Democratic Republic of the Congo, over 39,000 students in 69 schools have received nutritious meals through an ECW-funded programme delivered by UNICEF.

The needs are skyrocketing. With ongoing conflicts in places like the Democratic Republic of the Congo and Sudan creating ripple effects across Africa – and indeed across the globe – we must ensure that school meals in education investments remain at the top of the international humanitarian funding agenda.

ECW connects across various sectors to accelerate the collective impact of humanitarian funding. Together, we can keep hope alive for the 234 million crisis-impacted children that urgently need our support.

 


!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+’://platform.twitter.com/widgets.js’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);  

Excerpt:

Statement of International School Meals Day by Education Cannot Wait Director Yasmine Sherif

Women and Girls in Afghanistan Bear the Brunt of the Country’s Crisis

The President of the UN Security Council Briefs Press on Women Peace and Security in Afghanistan. Credit: UN Photo/Mark Garten

By Oritro Karim
UNITED NATIONS, Mar 13 2025 – Since the Taliban’s return to power in Afghanistan nearly four years ago, human rights have begun diminishing for over 14 million women. Heightened gender inequality has exacerbated the pre-existing humanitarian crisis in Afghanistan, which has been marked by conflict, displacement, climate change, food insecurity, and economic instability. In 2025, widespread cuts in humanitarian funding look to further strain the crisis.

The current humanitarian situation in Afghanistan is dire. According to the United Nations Assistance Mission in Afghanistan (UNAMA), roughly 50 percent of the population, or 23 million people, are dependent on humanitarian aid for survival.

United Nations (UN) Spokesperson Stéphane Dujarric states that approximately 55 people are killed or injured by unexploded ordnance each month, with most being children. A February 6 report from the Security Council also states that there are over a dozen terrorist groups in Afghanistan that pose “a serious challenge to the stability of the country, as well as to the security of Central Asian and other neighbouring states”.

Due to the Taliban’s numerous edicts targeting women’s rights in Afghanistan, women and girls have been hit the hardest by this protracted crisis. Currently, women are banned from most professions and forms of higher education. Women are also prohibited from entering public spaces without the presence of a male relative. Girls receive a limited education and are banned from attending schools beyond Grade 6.

It is predicted that if the Taliban’s edicts remain in place, Afghanistan’s economy could lose up to 9.6 billion dollars, which is equivalent to two-thirds of today’s gross domestic product. According to estimates from UN Women, 30 percent of all Afghan girls have never been to primary school. The removal of women and girls from educational facilities is linked with a 45 percent increase in child maternity rates as well as a 50 percent increase in maternal mortality rates.

The hunger crisis in Afghanistan remains widespread and disproportionately impacts women and girls. Expected to worsen in 2025, continued restrictions on women’s work and education, compounded with frequent climate shocks, has led to shortages in food production and widespread poverty. According to Dujarric, almost 3.5 million children under five years of age and over one million pregnant and breastfeeding women are projected to face acute malnourishment.

According to the Office for the Coordination of Humanitarian Affairs (OCHA), around 65 percent of the population lives in poverty, with large percentages also being susceptible to falling below the poverty line. These populations lack access to basic services such as healthcare, water and sanitation (WASH), and housing.

The World Food Programme (WFP) has stated that roughly 33 percent of Afghanistan’s population faces acute food insecurity. Two-thirds of female-led households struggle with accessing adequate amounts of food. The United Nations Children’s Fund (UNICEF) estimates that approximately 41 percent of Afghan children suffer from stunted growth, which is largely an irreversible effect of malnutrition.

On March 10, the UN Secretary-General’s Special Representative for Afghanistan, Roza Otunbayeva, briefed the Security Council on the current conditions in Afghanistan and how decreases in U.S. funding could exacerbate the humanitarian situation.

On the same day, U.S. Secretary of State Marco Rubio announced that the Trump administration had cancelled 83 percent of all USAID programs. “The 5200 contracts that are now cancelled spent tens of billions of dollars in ways that did not serve, (and in some cases even harmed), the core national interests of the United States,” said Rubio in a statement shared to X (formerly Twitter).

With the Taliban offering little to no government assistance and not establishing a self-sufficient economy in Afghanistan, the nation has historically been heavily dependent on foreign aid to stay afloat. These cuts in funding are projected to deal a significant blow to economic assistance for millions of Afghan people.

“The defunding of assistance is already having and will continue to have a significant impact on the Afghan people. In the past month, more than 200 health facilities have closed, impacting some 1.8 million people, essential malnutrition services for children have been limited and implementing partners have significantly reduced their footprint and coordination capacity. Lives and livelihoods will be lost and development gains further eroded,” said Otunbayeva.

According to a press statement from the United Nations Population Fund (UNFPA), the cuts in foreign aid to Afghanistan will significantly limit access to basic services. It is estimated that over 9 million people will lose access to health and protection services in 2025. Roughly 600 mobile health teams from both mental and physical healthcare centers will be at limited capability as well.

Women and girls will bear the brunt of the consequences of reduced foreign aid in Afghanistan. UNFPA Regional Director for Asia and the Pacific Pio Smith stated that between 2025 and 2028, there will be 1,200 additional maternal deaths and 109,000 additional accidental pregnancies as a result of aid cuts.

“Every two hours, a mother dies from preventable pregnancy complications, making Afghanistan one of the deadliest countries in the world for women to give birth. Without UNFPA’s support, even more lives will be lost at a time when the rights of Afghan women and girls are already being torn to pieces,” said Smith.

Afghanistan’s development will also take a substantial hit from a reduction of foreign aid from the US. According to the World Bank, Afghanistan is one of the world’s poorest and least developed countries. Despite the nation showing signs of growth in 2024, the economy remains fragile. A report from the Center for Global Development (CGD) states that Afghanistan is projected to experience a 7 percent setback in terms of economic development.

IPS UN Bureau Report

 


!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+’://platform.twitter.com/widgets.js’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);  

Activists Fear Kenya Forests Threatened Due to Government Development

Conservationists are preparing tree seedlings to boost reforestation efforts amidst growing concerns that Kenya is losing its forests. Credit: Joyce Chimbi/IPS

Conservationists are preparing tree seedlings to boost reforestation efforts amidst growing concerns that Kenya is losing its forests. Credit: Joyce Chimbi/IPS

By Joyce Chimbi
NAIROBI, Mar 13 2025 – After the controversial lifting of a six-year moratorium or temporary ban on logging activities in public and community forests by the Kenyan government in July 2023, trucks ferrying tree logs are frequently seen on major highways in total disregard of environmental concerns.

With just 12 percent tree cover and 8.8 percent forest cover, Kenya is one of the least forested countries in Africa. Of the country’s 1,100 native tree species, 10 percent are already threatened with extinction.

“Kenya’s government talks big on all matters climate change and even hosted the first-ever Africa Climate Summit in September 2023, just two months after lifting the 2018 moratorium on logging which was put in place to stop the widespread deforestation ongoing at that time,” says Auma Lynn Onyango, an environmentalist and active member of Mbunge La Mwananchi (People’s Parliament), a pro-poor social movement.

The consequences were immediate. The Kenya Forestry Research Institute (KEFRI) reported that six million eucalyptus trees were cut down in just six months, January to June 2024 for processed timber export to China and India. The loss is equivalent to five Karura forests. Karura Forest is 2,570 acres or 1,041 hectares, a protected urban forest and one of the biggest forests in the world that is entirely within a city.

Kenya’s forest cover is significantly declining, with reports indicating a continuous decrease in forest cover over the years. The East African country has fallen below the target of 10 percent forest cover as a minimum requirement set by the 2010 Kenyan constitution.

Amidst growing fears that the country’s forest wonderlands are vanishing with every load, the situation has worsened as the government’s development plans are destroying forests and their ecosystems, placing the country on a collision course with climate change.

Onyango tells IPS that even as the Kenyan government steps forward to host the second biennial Africa Climate Summit 2025, should no other country be up to the task, Karura Forest in Nairobi County is now one of several key forests in harm’s way as the government prioritises development over environmental protection.

Others are Suam Forest in Trans Nzoia County, Aberdare Forest which straddles four counties including Nyandarua, Nyeri, Murang’a, Kiambu and Laikipia in Kenya’s Aberdare Mountain Range and Oloolua Forest that straddles the border of Nairobi and Kajiado counties.

The government plans to allocate 50 acres of Suam Forest for the construction of a border town and housing project to support a one-stop border post with neighbouring Uganda. In 2020, the Nyandarua County government proposed selling 163 acres of Aberdare Forest to expand a local township and for dairy farming.

The government plans to widen and tarmac a dirt road across the Aberdare Mountain Range, which is currently under consideration for UNESCO World Heritage status for its unique landscape, diverse ecosystems and significant biodiversity, including rare species such as the mountain bongo antelope. The plans are on hold due to a court order. The Conservatory Order was extended to protect Aberdare National Park and Forest.

Further, the government intends to take 51.64 acres of Karura Forest for road expansion. The plan was halted by the Environment and Land Court in December 2024 in a court ruling following the Green Belt Movement’s petition to stop the development.

“But something very sinister and illegal seems to be happening in Karura Forest. When joggers first noticed significant cutting down of trees in the forest and took the issue to social media, the Kenya Forest Service responded and said that they are only removing old trees and that this was also happening in Thogoto Forest next door in Kiambu County to rejuvenate the forest,” Job Kamau, a Nairobi-based activist, tells IPS.

“That was in October 2024. Till now, the exotic trees are being removed and we are yet to see replanting of trees activities in these areas. We are being hoodwinked.”

Kamau says the Oloolua Forest situation exposed the double speak that defines the government’s position on environmental protection, conservation and preservation. An increase in illegal activities was first reported by the Oloolua Community Forest Association inside the forest that has an estimated 926 acres of endemic forest, 269 acres of degraded forest and 385 acres of eucalyptus plantation.

A portion of Oloolua forest land was allegedly grabbed and title deeds were issued to high-ranking government officials and politicians. The Oloolua community protested and raised alarm in April 2024, saying that no less than 66 acres of forest land had been grabbed by high-ranking people in government and parliament.

As a result of a public outcry, the Kenya Forest Service stopped the construction of a perimeter wall in Oloolua Forest. Kamau says, “Relevant government agencies pretended not to know who gave who land titles and permits to allow construction and the investigation we were promised into these illegal activities is yet to produce results seven months down the line. Title deeds and permits for construction are issued by government agencies.”

“In that same 2024, a developer, and again the government is in the dark as to their identity, was mapping and beginning construction of a restaurant and golf club in Ngong Forest, another gazetted forest land in Kajiado County close to Oloolua Forest,” he says.

Kimeli Winston, a resident of Ngong and a community-based conservationist, says high-ranking government officials have demonstrated an unprecedented “big appetite for land. Having grabbed public land in open spaces reserved for public institutions such as schools and other communal facilities such as playgrounds, they have gone back to our forests. We now believe that they kicked out forest communities to create room for themselves.”

Data from Global Forest Watch shows that from 2001 to 2023, Kenya lost 2.32 hectares of tree cover from fires and 384 hectares from all other drivers of loss. The year with the most tree cover loss due to fires during this period was 2022 with 190 hectares lost to fires — 2.9 percent of all tree cover loss for that year.

At this rate and with the lifting of the moratorium on logging and government development plans in forest land, Kenya’s majestic forests will eventually be confined to the annals of history.

IPS UN Bureau Report

 


!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+’://platform.twitter.com/widgets.js’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);  

IPS UN Bureau, IPS UN Bureau Report, Kenya

Trashing Jewish Values Risks Israel’s Survival as We Know It

A family gathers in a damaged building in Rafah in the southern Gaza Strip. 10 March 2025. Credit: World Food Program (WFP)

By Alon Ben-Meir
NEW YORK, Mar 13 2025 – 77 torturous years of the Israeli-Palestinian conflict, punctuated by intense violence and wars, successive Netanyahu-led governments have shattered Jewish values to the core—values that have sustained and preserved Jewish lives for centuries and provided the moral foundation on which Israel was built.

Throughout millennia of dispersion, the Jews had no army, no weapons, and no advanced technology to fight back against persecution, segregation, expulsion, and death, but they survived.

They persevered because they upheld these moral values at all times: in times of joy, in times of suffering, in times of loss, in times of gain, and in times of anxiety when they did not know what tomorrow would bring.

The historian Paul Johnson noted in his book A History of the Jews: “To [the Jews] we owe the idea of equality before the law, both divine and human; of the sanctity of life and the dignity of the human person; of the individual conscience and so of personal redemption; of the collective conscience and so of social responsibility; of peace as an abstract ideal and love as the foundation of justice, and many other items which constitute the basic moral furniture of the human mind.”

Tragically, these moral values have not resonated with Prime Minister Netanyahu and his ardent followers. From the first day he rose to power in 1996, he vowed to undermine the Oslo Accords, and swore to never allow the establishment of a Palestinian state under his watch. Since he returned to power in 2008, the Israeli-Palestinian relationship has hit a new nadir, and the prospect for peace is dimmer today than ever before.

Dehumanizing and brutalizing the Palestinians under occupation in the West Bank, tightening the blockade around Gaza, and categorically objecting to making any meaningful concessions to reach a peace agreement became his life-long mission, rendering the conflict increasingly intractable.

He facilitated the transfer of billions of dollars from Qatar to Hamas, which allowed Hamas to build a powerful militia that is still standing against Israel’s formidable military machine. Netanyahu convinced himself that Hamas was under control, but then came Hamas’ savage attack under his watch.

Though Hamas’ barbarism is unforgivable, and Israel has every right to defend itself, Netanyahu unleashed a retaliatory war against Hamas unparalleled in its scope and disproportionality. The war has laid two-thirds of Gaza in ruin; 47,600 Palestinians were killed, with half of those identified as women, children, or elderly, and over 100,000 have been injured.

Forcible and repeated displacement of 1.9 million people, restriction on deliveries of food, medicine, drinking water, and fuel, and the destruction of schools and hospitals, precipitated a humanitarian disaster unseen since Israel was created in 1948.

Revenge and torture, shooting to kill with no questions asked, and treating all Palestinians in Gaza—men, women, and the elderly—as legitimate targets as if they were all combatants, demonstrate the moral rot that has taken root in Israel.

Asa Kasher, one of Israel’s best-known philosophers, recently stated, “We heard a eulogy from the family of a soldier who was killed, who related how he burned homes and undertook acts of revenge. Where did this disturbed idea of revenge come from?”

These moral crimes have not only violated the laws of war but the very core of Jewish values. They have not brought back to life a single Israeli who was massacred by Hamas, they have only satisfied a corrupt Netanyahu-led government that functions like a criminal gang whose thirst for Palestinian blood is insatiable and would stop short of nothing to achieve its ends.

Furthermore, Netanyahu is using the cover of the Gaza war, where the whole world’s attention is focused, to ransack the West Bank.

During the past 17 months, 886 Palestinians were killed in the West Bank and 7,368 were injured. In 2024 alone, 841 homes in the West Bank and 219 homes in East Jerusalem were demolished. Additionally, as of the end of June 2024, 9,440 Palestinians have been detained on “security grounds,” including 226 minors.

There were 1,860 instances of Israeli settler violence against Palestinians from October 7, 2023, to December 31, 2024; under the watchful eyes of the police and the military, settlers regularly attacked Palestinian villages, setting fire to homes and cars, forcing thousands to abandon their homes and villages where they lived for hundreds of years.

As recently as January 2025, Israel launched a large-scale military operation in the West Bank, displacing 40,000 Palestinians, which is in line with Finance Minister Smotrich’s call for the annexation of the West Bank.

Given what the Jews have endured for centuries in foreign lands, it was once hard to imagine that any Israeli government would be capable of treating another human being the way that the Jews have been treated.

The Netanyahu-led government has steadily been trashing the values that provided the moral foundation of Israel, built on the ashes of the 6 million Jews who perished in the Holocaust; this tragic moral collapse of Israel has infected the Israeli public.

There has been hardly any pushback from Israelis, 80 percent of whom were born after 1967. For them, the occupation has become a way of life—the suppression and incarceration of Palestinians is normal, dispossession of their land is a given, demolishing their houses is unvarying, and night raids are another good measure to instill constant anxiety and fear in their hearts.

The Israelis, many of whom have grown numb to the Palestinians’ daily suffering, should wake up for a brief moment and watch what is being done in their name, internalize the daily tragedies that are being inflicted on so many innocent civilians whose only guilt is being Palestinians. Isn’t that evocative of the Jews’ persecution, whose guilt was just being Jewish?

This total betrayal of Jewish values should send shivers through their spines as it has for every decent human being.

Netanyahu does not want peace. Maintaining perpetual conflict with the Palestinians would allow him to usurp more Palestinian land through coercion, intimidation, and violence than what he can gain through a peaceful negotiating process.

He persistently paints the Palestinians as an existential threat while using night raids, home demolitions, and more to provoke them into committing acts of violence to justify the occupation on national security grounds, while gobbling up their land bite by bite.

Netanyahu opposes a Palestinian state but offers no alternative to a two-state solution. He must show the world another option where both sides can live in peace and security short of that. Is the annexation of the West Bank the answer?

It will do nothing but erase Israel’s Jewish character and deprive it of living in security and peace, defying its founders’ vision and its reason for being. Ninety percent of all living Palestinians were born under occupation. They are left hopeless and despairing and have nothing left to lose.

A fourth generation of youth will now live to avenge the calamity that has befallen their people. What fate will await them? They would rather die as martyrs than live hopelessly in servitude. It will not be if but when a new inferno erupts at a magnitude never seen before.

Netanyahu is champing at the bit to exile the Palestinians from Gaza, courtesy of Trump, who is clueless about the horror that will unfold should he act on his brazen idea. However, Netanyahu’s dream of a greater Israel will be nothing but a lasting nightmare.

Israel will never be able to sustain itself on the ashes of the Palestinians. By forsaking Jewish values, Netanyahu is destroying the moral foundation on which the country stands. The Israelis must remember that the values that guarded the Jews’ survival throughout the millennia must be restored to ensure the survival of the country and, indeed, its very soul.

Dr. Alon Ben-Meir is a retired professor of international relations, most recently at the Center for Global Affairs at NYU. He taught courses on international negotiation and Middle Eastern studies.

IPS UN Bureau

 


!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+’://platform.twitter.com/widgets.js’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);  

Anglo American’s Mogalakwena PGM mine completes IRMA audit

SEATTLE, March 13, 2025 (GLOBE NEWSWIRE) — Today the Initiative for Responsible Mining Assurance (IRMA) released the audit report of Anglo American’s Mogalakwena PGM complex against the IRMA Standard for Responsible Mining. Independent audit firm ERM–CVS assessed Mogalakwena at IRMA 50 when measuring its performance against the Standard’s best practice social and environmental criteria.

IRMA 50 means that ERM–CVS verified that the operations at least substantially met all 40 critical requirements of the IRMA Standard, as well as at least 50% of the Standard’s criteria in each of the four principle areas: social responsibility, environmental responsibility, business integrity and planning for positive legacies. The full audit reports are available on the Mogalakwena audit page on the IRMA website.

The information stakeholders need to decide what’s going well — and what may require more attention.

“This report demonstrates that mines can point to transparent, independent evaluations of their environmental and social performance,” said Aimee Boulanger, Executive Director of IRMA. “Through detailed IRMA audit reports, mining companies, communities and companies that purchase mined materials can gain the information they need, to decide what’s going well — and what may require more attention — at specific mines.”

As the IRMA Standard is recognized and adopted around the globe, these audits are steps in a deepening dialogue between mining companies and those affected by their operations. Because the process is still evolving, the results should be reviewed and interpreted accordingly.

“An increasing number of community members and workers are engaging in IRMA audits, and they’re using the audit reports to communicate directly with the mining company about their priorities for improvement,” Ms. Boulanger said. “If readers find results inconsistent with their experience, we encourage them to share their perspectives with IRMA and the company so that we can improve the audit review process and support continuing improvement at the site—as community members and NGOs have already done in this case.”

“We are always looking to improve not only mining practices, but also IRMA's system. IRMA's improvements, and being transparent about how we need to improve, is built into our system and a measure of its success,” said Ms. Boulanger.

Craig Miller, CEO of Anglo American Platinum said, “This milestone at Mogalakwena is significant in our overall adoption of IRMA. It enables us to promote transparency and best practice in sustainability, while adding value to our global customers by helping them meet the increasing expectations for responsibly mined materials in an efficient and credible way. With IRMA 50, we have accomplished our sustainable mining plan target of having all our mining operations assured against a recognised responsible mining standard by 2025.”

Including Mogalakwena, 23 industrial–scale mines worldwide are within the IRMA independent assessment system. After an initial self–assessment, a participating mine engages a third–party audit firm — trained and approved by IRMA — to conduct a detailed independent evaluation, including on–site visits to the mine and nearby communities. Following the release of the initial audit, a shorter surveillance audit checks on the mine’s performance. Three years after the initial audit, the operation is fully audited again (Note: The first mines audited in the IRMA system have had extensions to this timeline due to Covid delays and launch–phase learning; updated full reviews will be required to maintain or increase achievement scores.)

The independent IRMA system is the only global mining standard that provides equal power to the public sector (communities and Indigenous rights holders, mine workers, and environmental and human rights advocates) alongside the private sector (mining companies, mined materials purchasers and investors).

For More Information:


GLOBENEWSWIRE (Distribution ID 9393841)

Nyxoah Publie ses Résultats Financiers et Opérationnels pour le Quatrième Trimestre et l'Exercice 2024

INFORMATIONS RÉGLEMENTÉES

Nyxoah Publie ses Résultats Financiers et Opérationnels pour le Quatrième Trimestre et l'Exercice 2024
L'examen de la demande d'autorisation de mise sur le marché de la FDA touche à sa fin
Prêt pour un lancement commercial aux États–Unis au cours en mars 2025

Mont–Saint–Guibert, Belgique – 13 mars 2025, 7h00 CET / 2h00 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (« Nyxoah » ou la « Société ») une société de technologie médicale développant des alternatives thérapeutiques innovantes pour l'apnée obstructive du sommeil (AOS) par la neuromodulation, a publié aujourd’hui ses résultats financiers et opérationnels pour le quatrième trimestre et l'exercice 2024.

Temps Forts Financiers et d’Exploitation

  • Le chiffre d'affaires du quatrième trimestre 2024 s'élève à 1,3 million d'euros, ce qui exclut 0,6 million d'euros de revenus différés
  • Le chiffre d'affaires pour l'année 2024 s'élève à 4,5 millions d'euros, ce qui exclut 0,6 million d'euros de revenus différés
  • La marge brute pour le quatrième trimestre 2024 était de 73%
  • Au 31 décembre 2024, la trésorerie et les actifs financiers s'élevaient à 85,6 millions, contre 57,7 millions d'euros au 31 décembre 2023
  • Une équipe de direction américaine constituée avec une grande expérience de l'industrie
  • La mise en place de l’organisation commerciale complète aux États–Unis, comprenant des équipes de vente, de marketing et d'accès au marché est complétée

“2024 a été une année de transformation pour Nyxoah. Nous avons rapporté les résultats de premier plan de notre étude pivot DREAM, achevé notre soumission PMA auprès de la FDA pour Genio, et construit une organisation commerciale américaine de classe mondiale”, a commenté Olivier Taelman, CEO de Nyxoah. “Nous pensons qu'une approbation est toujours attendue d'ici la fin du premier trimestre, et nous sommes impatients d'apporter cette thérapie innovante aux millions d'Américains souffrant d'AOS modéré à sévère.”

Résultats du Quatrième Trimestre et de l'Année 2024

Revenus
Au quatrième trimestre 2024, la Société a commencé à enregistrer une partie du prix de vente d'un système Genio lié aux patchs jetables en tant que produits différés et a comptabilisé 0,6 million d'euros au cours du trimestre. En raison de ce report, le chiffre d'affaires déclaré était de 1,3 million d'euros pour le quatrième trimestre se terminant le 31 décembre 2024, et de 4,5 millions d'euros pour l'ensemble de l'année. Si la Société n'avait pas enregistré de produits différés pour ses patchs jetables, le chiffre d'affaires total du quatrième trimestre aurait été de 1,9 million d'euros, soit une hausse de 46% par rapport au troisième trimestre 2024. De même, le chiffre d'affaires pour l'ensemble de l'année 2024 aurait été de 5,1 millions d'euros, en hausse de 18% par rapport à 4,3 millions d'euros en 2023. L'augmentation du chiffre d'affaires sur l'ensemble de l'année s'explique par la commercialisation par la Société du système Genio®, principalement en Allemagne.

Coût des Marchandises Vendues
Le coût des marchandises vendues s'est élevé à 0,3 million d'euros pour le trimestre clos le 31 décembre 2024, soit un bénéfice brut de 0,9 million d'euros, ou une marge brute de 73%. À titre de comparaison, le coût total des marchandises vendues était de 0,7 million d'euros au quatrième trimestre 2023, pour un bénéfice brut de 1,1 million d'euros, soit une marge brute de 60%.

Pour l'ensemble de l'année se terminant le 31 décembre 2024, le coût total des marchandises vendues s'est élevé à 1,5 million d'euros, soit un bénéfice brut de 3,0 millions d'euros, ou une marge brute de 66%. À titre de comparaison, le coût total des marchandises vendues était de 1,7 million d'euros pour l'ensemble de l'année 2023, soit un bénéfice brut de 2,7 millions d'euros, ou une marge brute de 62%.

Frais de Recherche et de Développement
Pour le quatrième trimestre se terminant le 31 décembre 2024, les dépenses de recherche et développement se sont élevées à 11,7 millions d'euros, contre 7,3 millions d'euros pour le quatrième trimestre se terminant le 31 décembre 2023. Pour l'année entière se terminant le 31 décembre 2024, les frais de recherche et développement étaient de 34,3 millions d'euros, contre 26,7 millions d'euros pour l'année entière de 2023. L'augmentation des frais de recherche et de développement est principalement due à la hausse des activités de R&D et des dépenses cliniques.

Frais commerciaux, Généraux et Administratifs
Pour le quatrième trimestre se terminant le 31 décembre 2024, les frais commerciaux, généraux et administratifs se sont élevés à 8,1 millions d'euros, contre 4,9 millions d'euros pour le quatrième trimestre se terminant le 31 décembre 2023. Pour l'ensemble de l'exercice clos le 31 décembre 2024, les frais commerciaux, généraux et administratifs se sont élevés à 28,5 millions d'euros, contre 21,7 millions d'euros pour l'ensemble de l'exercice 2023. L'augmentation des frais commerciaux, généraux et administratifs est principalement due à une augmentation des coûts pour soutenir la commercialisation du système Genio® en Europe et le développement de la Société.

Perte d'Exploitation
Pour le quatrième trimestre se terminant le 31 décembre 2024, les frais commerciaux, généraux et administratifs se sont élevés à 8,1 millions d'euros, contre 5,4 millions d'euros pour le quatrième trimestre se terminant le 31 décembre 2023. Pour l'ensemble de l'exercice clos le 31 décembre 2024, les frais commerciaux, généraux et administratifs se sont élevés à 28,5 millions d'euros, contre 21,7 millions d'euros pour l'ensemble de l'exercice 2023. L'augmentation des frais commerciaux, généraux et administratifs est principalement due à une augmentation des coûts pour soutenir la commercialisation du système Genio® en Europe et la mise à l'échelle de la Société.

Position de Trésorerie
Au 31 décembre 2024, la trésorerie et les actifs financiers s'élevaient à 85,6 millions d'euros, contre 57,7 millions d'euros au 31 décembre 2023.

Rapport annuel 2024

Nyxoah finalise actuellement les états financiers pour l'exercice clos le 31 décembre 2024. L'auditeur indépendant de la Société a confirmé que ses procédures d'audit, qui sont en grande partie terminées, n'ont pas révélé d'ajustements importants qui devraient être apportés aux informations comptables incluses dans ce communiqué de presse. Les états financiers consolidés complets pour l'exercice clos le 31 décembre 2024 ainsi que le rapport d'audit complet relatif à l'audit des états financiers consolidés figureront dans le rapport annuel 2024 que la Société entend publier le 20 mars 2025 ou aux alentours de cette date. Une fois publié, le rapport annuel de Nyxoah pour l'exercice 2024 sera disponible sur la page investisseurs du site web de Nyxoah (https://investors.nyxoah.com/financials).

Conférence téléphonique et présentation par webcast
Le management de la Société organisera une conférence téléphonique pour discuter ses résultats financiers le même jour, à 13h00 CET / 8h00 ET.

La retransmission de la conférence téléphonique sera accessible sur la page Investor Relations du site web de Nyxoah ou par le biais de ce lien : Nyxoah's Q4 and FY 2024 Earnings Call Webcast. Pour ceux qui n'ont pas l'intention de poser une question au Management, la Société recommande d'écouter la webdiffusion.

Si vous avez l'intention de poser une question, veuillez utiliser le lien suivant : Nyxoah's Q4 and FY 2024 Earnings Call. Après l'inscription, un courriel sera envoyé, comprenant les détails de la connexion et un code d'accès unique à la conférence téléphonique nécessaire pour rejoindre l'appel en direct. Pour s'assurer que vous êtes connecté avant le début de la conférence, la Société suggère de s'inscrire au moins 10 minutes avant le début de l'appel.

Le webcast archivé pourra être réécouté peu après la clôture de la conférence.

COMPTE DE RESULTATS CONSOLIDÉS POUR LE QUATRIEME TRIMESTRE ET LES EXERCICES CLOS AU 31 DÉCEMBRE 2024 ET 31 DÉCEMBRE 2023 (NON–AUDITÉS)
(en milliers)

  Pour la période de trois mois terminée le 31 décembre   Pour l’année terminée le 31 décembre
  2024    2023   2024   2023  
Chiffre d'affaires 1 263   €1 824   €4 521   €4 348  
Coût des biens vendus (335)   (726)   (1 552)   (1 656)  
Bénéfice brut €928   €1 098   €2 969   €2 692  
Frais de recherche et de développement (11 752)   (7 321)   (34 325)   (26 651)  
Frais de vente, dépenses administratives et autres frais généraux (8 065)   (4 893)   (28 461)   (21 687)  
Autres revenus / (frais) d'exploitation 578   279   1 008   544  
Perte d'exploitation de la période €(18 311)   €(10 837)   €(58 809)   €(45 102)  
Produits financiers 2 832   582   7 447   4 174  
Charges financières 410   (964)   (5 070)   (3 729)  
Perte de la période avant impôts €(15 069)   €(11 219)   €(56 432)   €(44 657)  
Impôts sur le revenu (2 080)   326   2 804   1 445  
Perte de la période €(17 149)   €(10 893)   €(59 236)   €(43 212)  
                 
Perte attribuable aux actionnaires €(17 149)   €(10 893)   €(59 236)   €(43 212)  
                 
Autres éléments du résultat global                
Éléments qui ne peuvent pas être reclassés ultérieurement en profit ou perte (nets d'impôts)                
Réévaluation des obligations au titre des avantages postérieurs à l’emploi, déduction faite de l’impôt 11   81   11   81  
Éléments susceptibles d’être reclassés ultérieurement en résultat net d’impôt                
Différences de conversion des devises 545   (32)   766   (120)  
Total des autres éléments du résultat global €556   €(39)   €777   €(39(  
Total du résultat global de l’exercice, déduction faite de l’impôt €(16 151)   €(10 844)   € (58 459)   € (43 251)  
Perte attribuable aux actionnaires €(16 151)   €(10 844)   € (58 459)   € (43 251)  
                     
Perte par action (en €) €(463)   €(379)   €(1 809)   €(1 545)  
Perte diluée par action (en €) €(463)   €(379)   €(1 809)   €(1 545)  

 
ÉTAT CONSOLIDÉ DE LA SITUATION FINANCIÈRE (NON–AUDITÉ)

(en milliers)

             
        Au 31 décembre
        2024   2023
ACTIFS            
Actifs non courants            
Immobilisations corporelles       4 753   4 188
Immobilisations incorporelles       50 381   46 608
Droit d'utilisation d'actifs       3 496   3 788
Actif d'impôts différés       76   56
Autres créances à long terme       1 617   1 166
        € 60 323   € 55 806
Actifs courants            
Stocks       4 716   3 315
Créances commerciales       3 382   2 758
Autres créances       2 774   3 212
Autres actifs courants       1 656   1 318
Actifs financiers       51 369   36 138
Trésorerie et équivalents de trésorerie       34 186   21 610
        € 98 083   € 68 351
Total de l'actif       € 158 406   € 124 157
             
CAPITAUX PROPRES ET PASSIFS            
Capital et réserves            
Capital       6 430   4 926
Prime d'émission       314 345   246 127
Réserve pour paiement fondés sur des actions       9 300   7 661
Autres éléments du résultat global       914   137
Résultats reportés       (217 735)   (160 829)
Total des capitaux propres attribuables aux actionnaires       € 113 254   € 98 022
             
PASSIFS            
Passifs non courants            
Dettes financières       18 725   8 373
Passifs locatifs       2 562   3 116
Passifs au titre des retraites         9
Provisions       1 000   185
Passif d'impôts différés       19   9
Passif au titre de contrats avec des clients       472  
Autres passifs       845  
        € 23 623   € 11 692
Passifs courants            
Dettes financières       248   364
Passifs locatifs       1 118   851
Dettes commerciales       9 505   8 108
Passif d'impôts exigibles       4 317   1 988
Passif au titre de contrats avec des clients       117  
Autres passifs       6 224   3 132
        € 21 529   € 14 443
Total du passif       € 45 152   € 26 135
Total des capitaux propres et du passif       € 158 406   € 124 157

À propos de Nyxoah
Nyxoah réinvente le sommeil pour le milliard de personnes qui souffrent d'apnée obstructive du sommeil (AOS). Nous sommes une société de technologie médicale qui développe des alternatives de traitement révolutionnaires pour l'AOS grâce à la neuromodulation. Notre première innovation est Genio®, un dispositif de neuromodulation hypoglosse sans pile, inséré par une simple incision sous le menton et contrôlé par un dispositif portable. Grâce à notre engagement en faveur de l'innovation et des preuves cliniques, nous avons obtenu les meilleurs résultats de sa catégorie en matière de réduction du fardeau du SAOS.

À la suite de l'achèvement réussi de l'étude BLAST OSA, le système Genio® a reçu son marquage CE européen en 2019. Nyxoah a réalisé deux introductions en bourse réussies : sur Euronext Bruxelles en septembre 2020 et sur le NASDAQ en juillet 2021. À la suite des résultats positifs de l'étude BETTER SLEEP, Nyxoah a reçu l'approbation du marquage CE pour l'élargissement de ses indications thérapeutiques aux patients atteints d'effondrement concentrique complet (CCC), actuellement contre–indiqués dans la thérapie des concurrents. En outre, la société a annoncé les résultats positifs de l'étude pivot DREAM IDE en vue de l'approbation de la FDA et de la commercialisation aux États–Unis.

Pour plus d’informations, visitez http://www.nyxoah.com/

Attention – Marquage CE depuis 2019. Dispositif expérimental aux États–Unis. Limité par la loi fédérale américaine à une utilisation expérimentale aux États–Unis.

Déclarations prospectives

Certaines déclarations, croyances et opinions contenues dans le présent communiqué de presse sont de nature prospective et reflètent les attentes actuelles de la société ou, le cas échéant, des administrateurs ou de la direction de la société concernant le système Genio®, les études cliniques prévues et en cours sur le système Genio®, les avantages potentiels du système Genio®, les objectifs de Nyxoah concernant le développement, la voie réglementaire et l'utilisation potentielle du système Genio®, l'utilité des données cliniques pour l'obtention éventuelle de l'approbation de la FDA pour le système Genio®, l'obtention de l'approbation de la FDA, l'entrée sur le marché américain et les résultats des opérations de la société, sa situation financière, ses liquidités, sa performance, ses perspectives, sa croissance et ses stratégies. Les résultats d'exploitation, la situation financière, les liquidités, les performances, les perspectives, la croissance et les stratégies de la société. De par leur nature, les déclarations prévisionnelles impliquent un certain nombre de risques, d'incertitudes, d'hypothèses et d'autres facteurs qui pourraient faire en sorte que les résultats ou événements réels diffèrent matériellement de ceux exprimés ou sous–entendus dans les déclarations prévisionnelles. Ces risques, incertitudes, hypothèses et facteurs pourraient avoir une incidence négative sur les résultats et les effets financiers des plans et des événements décrits dans le présent document. En outre, ces risques et incertitudes comprennent, sans s'y limiter, les risques et incertitudes énoncés dans la section « Facteurs de risque “ du rapport annuel de la société sur le formulaire 20–F pour l'exercice clos le 31 décembre 2023, déposé auprès de la Securities and Exchange Commission (” SEC ») le 20 mars 2024, et des rapports ultérieurs que la société dépose auprès de la SEC. Une multitude de facteurs, y compris, mais sans s'y limiter, les changements dans la demande, la concurrence et la technologie, peuvent faire en sorte que les événements, les performances ou les résultats réels diffèrent de manière significative de tout développement anticipé. Les déclarations prospectives contenues dans le présent communiqué de presse concernant des tendances ou des activités passées ne constituent pas des garanties de performances futures et ne doivent pas être considérées comme une déclaration selon laquelle ces tendances ou activités se poursuivront à l'avenir. En outre, même si les résultats ou les développements réels sont conformes aux déclarations prospectives contenues dans le présent communiqué de presse, ces résultats ou développements peuvent ne pas être indicatifs des résultats ou développements des périodes futures. Aucune déclaration ou garantie n'est donnée quant à l'exactitude ou à la justesse de ces déclarations prévisionnelles. En conséquence, la Société décline expressément toute obligation ou tout engagement de publier des mises à jour ou des révisions des déclarations prospectives contenues dans le présent communiqué de presse à la suite d'un changement des attentes ou d'un changement des événements, conditions, hypothèses ou circonstances sur lesquels ces déclarations prospectives sont basées, sauf si la loi ou la réglementation l'exige expressément. Ni la Société, ni ses conseillers ou représentants, ni aucune de ses filiales, ni les dirigeants ou employés de ces personnes ne garantissent que les hypothèses sous–jacentes à ces déclarations prospectives sont exemptes d'erreurs et n'acceptent aucune responsabilité quant à l'exactitude future des déclarations prospectives contenues dans ce communiqué de presse ou quant à la survenance effective des développements prévus. Vous ne devriez pas accorder une confiance excessive aux déclarations prospectives, qui ne sont valables qu'à la date du présent communiqué de presse.

Contacts :

Nyxoah
John Landry, CFO
[email protected]

Medias
États–Unis
FINN Partners – Glenn Silver
[email protected]

Belgique/France
Backstage Communication – Gunther De Backer
[email protected]

International/Allemagne
MC Services – Anne Hennecke
nyxoah@mc–services.eu

Pièce jointe


GLOBENEWSWIRE (Distribution ID 1001053522)

Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results

REGULATED INFORMATION

Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results
FDA PMA Application Review Nearing Conclusion
Positioned for U.S. Commercial Launch in March 2025

Mont–Saint–Guibert, Belgium – March 13, 2024, 7:00am CET / 2:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today reported financial and operating results for the fourth quarter and financial year 2024.  

Recent Financial and Operating Highlights

  • Revenue for the fourth quarter of 2024 was €1.3 million, which excludes €0.6 million of deferred revenue
  • Revenue for the full year 2024 was €4.5 million, which excludes €0.6 million of deferred revenue
  • Gross margin for the fourth quarter of 2024 was 73%
  • At December 31, 2024, cash and financial assets were €85.6 million, compared to €57.7 million at December 31, 2023
  • Assembled U.S. executive leadership team with deep industry experience
  • Full U.S. commercial organization, including sales, marketing, and market access teams, in place

“2024 was a transformative year for Nyxoah. We reported best–in–class outcomes from our DREAM pivotal study, completed our PMA submission with the FDA for Genio, and built a world–class U.S. commercial organization,” commented Olivier Taelman, Nyxoah's Chief Executive Officer. “We believe an approval is still expected by the end of the first quarter, and we look forward to launching this innovative therapy to the millions of Americans suffering from moderate to severe OSA.”

Fourth Quarter and Full Year 2024 Results

Revenue

In the fourth quarter of 2024, the Company began recording a portion of the selling price for a Genio system related to disposable patches as deferred revenue and recognized €0.6 million in the quarter. Due to this deferral, reported revenue was €1.3 million for the fourth quarter ending December 31, 2024, and €4.5 million for the full year. Had the Company not recorded deferred revenue for its disposable patches, total revenue for the fourth quarter would have €1.9 million, up 46% versus the third quarter of 2024. Likewise, revenue for the full year 2024 would have been €5.1 million, up 18% from €4.3 million in 2023. The increase in full year revenue was attributable to the Company’s commercialization of the Genio® system, primarily in Germany.

Cost of Goods Sold

Cost of goods sold was €0.3 million for the three months ending December 31, 2024, representing a gross profit of €0.9 million, or gross margin of 73%. This compares to total cost of goods sold of €0.7 million in the fourth quarter of 2023, for a gross profit of €1.1 million, or gross margin of 60%.

For the full year ending December 31, 2024, total cost of goods sold was €1.5 million, representing a gross profit of €3.0 million, or gross margin of 66%. This compares to total cost of goods sold of €1.7 million for the full year of 2023, for a gross profit of €2.7 million, or gross margin of 62%.

Research and Development
For the fourth quarter ending December 31, 2024, research and development expenses were €11.7 million, versus €7.3 million for the fourth quarter ending December 31, 2023. For the full year ending December 31, 2024, research and development expenses were €34.3 million, versus €26.7 million for the full year of 2023. The increase in research and development expenses was primarily driven by higher R&D activities and clinical expenses.

Selling, General and Administrative
For the fourth quarter ending December 31, 2024, selling, general and administrative expenses were €8.1million, versus €4.9 million for the fourth quarter ending December 31, 2023. For the full year ending December 31, 2024, selling, general and administrative expenses were €28.5 million, versus €21.7 million for the full year of 2023. The increase in selling, general and administrative expenses was mainly due to an increase of costs to support the commercialization of Genio® system in Europe and scale up of the Company.

Operating Loss
Total operating loss for the fourth quarter and full year 2024 was €18.3 million and €58.8 million, respectively, versus €10.8 million and €45.1 million in the fourth quarter and full year 2023, respectively. This was driven by the acceleration in the Company’s R&D spending, as well as ongoing commercial and clinical activities.

Cash Position
As of December 31, 2024, cash and financial assets totaled €85.6 million, compared to €57.7 million on December 31, 2023.

Annual Report 2024
Nyxoah is currently finalizing the financial statements for the year ended December 31, 2024. The Company’s independent auditor has confirmed that their audit procedures, which have been substantially completed, have not revealed any material adjustments which would have to be made to the accounting information included in this press release. The complete consolidated financial statements for the year ended December 31, 2024 as well as the complete audit report related to the audit of the consolidated financial statements will be included in the 2024 Annual Report which the Company aims to publish on or around March 20, 2025. When published, the Nyxoah Annual Report for the financial year 2024 will be available on the investor page of Nyxoah’s website (https://investors.nyxoah.com/financials).

Conference call and webcast presentation
Company management will host a conference call to discuss financial results on Thursday, March 13, 2025, beginning at 1:00pm CET / 8:00am ET.

A webcast of the call will be accessible via the Investor Relations page of the Nyxoah website or through this link: Nyxoah's Q4 and FY 2024 Earnings Call Webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast.

If you plan to ask a question, please use the following link: Nyxoah's Q4 and FY 2024 Earnings Call. After registering, an email will be sent, including dial–in details and a unique conference call access code required to join the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a minimum of 10 minutes before the start of the call.

The archived webcast will be available for replay shortly after the close of the call.

CONSOLIDATED STATEMENTS OF LOSS AND OTHER COMPREHENSIVE LOSS (unaudited)
(in thousands)

 

For the three months ended December 31,

 

For the twelve months ended December 31,

 

2024

 

2023

 

2024

 

2023

Revenue 

1 263

 

1 824

 

4 521

 

4 348

Cost of goods sold 

(335)

 

(726)

 

(1 552)

 

(1 656)

Gross profit 

928

 

€ 1 098

 

2 969

 

€ 2 692

Research and Development Expense 

(11 752)

 

(7 321)

 

(34 325)

 

(26 651)

Selling, General and Administrative Expense 

(8 065)

 

(4 893)

 

(28 461)

 

(21 687)

Other income/(expense) 

578

 

279

 

1 008

 

544

Operating loss for the period 

€(18 311)

 

€(10 837)

 

€(58 809)

 

€(45 102)

Financial income 

2 832

 

582

 

7 447

 

4 174

Financial expense 

410

 

(964)

 

(5 070)

 

(3 729)

Loss for the period before taxes 

€(15 069)

 

€(11 219)

 

€(56 432)

 

€(44 657)

Income taxes

(2 080)

 

326

 

(2 804)

 

1 445

Loss for the period 

€(17 149)

 

€(10 893)

 

€(59 236)

 

€(43 212)

 

 

 

 

 

 

 

 

Loss attributable to equity holders 

€(17 149)

 

€(10 893)

 

€(59 236)

 

€(43 212)

 

 

 

 

 

 

 

 

Other comprehensive income/(loss) 

 

 

 

 

 

 

 

Items that may not be subsequently reclassified to profit or loss (net of tax) 

 

 

 

 

 

 

 

Remeasurements of post–employment benefit obligations, net of tax

11

 

81

 

11

 

81

Items that may be subsequently reclassified to profit or loss (net of tax)

 

 

 

 

 

 

 

Currency translation differences 

545

 

(32)

 

766

 

(120)

Total other comprehensive income/(loss)

556

 

€(39)

 

€777

 

€(39)

Total comprehensive loss for the year, net of tax 

€(16 151)

 

€ (10 844)

 

€(58 459)

 

€(43 251)

Loss attributable to equity holders 

€(16 151)

 

€ (10 844)

 

€(58 459)

 

(43 251)

 

 

 

 

 

 

 

 

Basic loss per share (in EUR) 

€(463)

 

€(379)

 

€(1 809)

 

€(1 545)

Diluted loss per share (in EUR) 

€(463)

 

€(379)

 

€(1 809)

 

€(1 545)

CONSOLIDATED BALANCE SHEET (unaudited)
(in thousands)

 

 

 

As at December 31

 

 

 

2024

 

2023

ASSETS

 

 

 

 

 

Non–current assets

 

 

 

 

 

Property, plant and equipment

 

 

4 753

 

4 188

Intangible assets

 

 

50 381

 

46 608

Right of use assets

 

 

3 496

 

3 788

Deferred tax asset

 

 

76

 

56

Other long–term receivables

 

 

1 617

 

1 166

 

 

 

€ 60 323

 

€ 55 806

Current assets

 

 

 

 

 

Inventory

 

 

4 716

 

3 315

Trade receivables

 

 

3 382

 

2 758

Other receivables

 

 

2 774

 

3 212

Other current assets

 

 

1 656

 

1 318

Financial assets

 

 

51 369

 

36 138

Cash and cash equivalents

 

 

34 186

 

21 610

 

 

 

€ 98 083

 

€ 68 351

Total assets

 

 

€ 158 406

 

€ 124 157

 

 

 

 

 

 

EQUITY AND LIABILITIES

 

 

 

 

 

Share capital and reserves

 

 

 

 

 

Share capital

 

 

6 430

 

4 926

Share premium

 

 

314 345

 

246 127

Share based payment reserve

 

 

9 300

 

7 661

Other comprehensive income

 

 

914

 

137

Retained loss

 

 

(217 735)

 

(160 829)

Total equity attributable to shareholders

 

 

€ 113 254

 

€ 98 022

 

 

 

 

 

 

LIABILITIES

 

 

 

 

 

Non–current liabilities

 

 

 

 

 

Financial debt

 

 

18 725

 

8 373

Lease liability

 

 

2 562

 

3 116

Pension liability

 

 

 

9

Provisions

 

 

1 000

 

185

Deferred tax liability

 

 

19

 

9

Contract liability

 

 

472

 

Other liabilities

 

 

845

 

 

 

 

€ 23 623

 

€ 11 692

Current liabilities

 

 

 

 

 

Financial debt

 

 

248

 

364

Lease liability

 

 

1 118

 

851

Trade payables

 

 

9 505

 

8 108

Current tax liability

 

 

4 317

 

1 988

Contract liability

 

 

117

 

Other liabilities

 

 

6 224

 

3 132

 

 

 

€ 21 529

 

€ 14 443

Total liabilities

 

 

€ 45 152

 

€ 26 135

Total equity and liabilities

 

 

€ 158 406

 

€ 124 157

About Nyxoah
Nyxoah is reinventing sleep for the billion people that suffer from obstructive sleep apnea (OSA). We are a medical technology company that develops breakthrough treatment alternatives for OSA through neuromodulation. Our first innovation is Genio®, a battery–free hypoglossal neuromodulation device that is inserted through a single incision under the chin and controlled by a wearable. Through our commitment to innovation and clinical evidence, we have shown best–in–class outcomes for reducing OSA burden.

Following the successful completion of the BLAST OSA study, the Genio® system received its European CE Mark in 2019. Nyxoah completed two successful IPOs: on Euronext Brussels in September 2020 and NASDAQ in July 2021. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company announced positive outcomes from the DREAM IDE pivotal study for FDA and U.S. commercialization approval.

For more information, please visit http://www.nyxoah.com/.

Caution – CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.

Forward–looking statements

Certain statements, beliefs and opinions in this press release are forward–looking, which reflect the Company’s or, as appropriate, the Company directors’ or managements’ current expectations regarding the Genio® system; planned and ongoing clinical studies of the Genio® system; the potential advantages of the Genio® system; Nyxoah’s goals with respect to the development, regulatory pathway and potential use of the Genio® system; the utility of clinical data in potentially obtaining FDA approval of the Genio® system; receipt of FDA approval; entrance to the U.S. market; and the Company's results of operations, financial condition, liquidity, performance, prospects, growth and strategies. By their nature, forward–looking statements involve a number of risks, uncertainties, assumptions and other factors that could cause actual results or events to differ materially from those expressed or implied by the forward–looking statements. These risks, uncertainties, assumptions and factors could adversely affect the outcome and financial effects of the plans and events described herein. Additionally, these risks and uncertainties include, but are not limited to, the risks and uncertainties set forth in the “Risk Factors” section of the Company’s Annual Report on Form 20–F for the year ended December 31, 2023, filed with the Securities and Exchange Commission (“SEC”) on March 20, 2024, and subsequent reports that the Company files with the SEC. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward looking statements contained in this press release regarding past trends or activities are not guarantees of future performance and should not be taken as a representation that such trends or activities will continue in the future. In addition, even if actual results or developments are consistent with the forward–looking statements contained in this press release, those results or developments may not be indicative of results or developments in future periods. No representations and warranties are made as to the accuracy or fairness of such forward–looking statements. As a result, the Company expressly disclaims any obligation or undertaking to release any updates or revisions to any forward–looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward–looking statements are based, except if specifically required to do so by law or regulation. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person's officers or employees guarantees that the assumptions underlying such forward–looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward–looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward–looking statements, which speak only as of the date of this press release.

Contacts:

Nyxoah
John Landry – CFO
[email protected]

For Media
United States
FINN Partners – Glenn Silver
[email protected]

Belgium/France
Backstage Communication – Gunther De Backer
[email protected]

International/Germany
MC Services – Anne Hennecke
nyxoah@mc–services.eu

Attachment


GLOBENEWSWIRE (Distribution ID 1001053522)